Longeveron Inc.

Longeveron Inc.

Biotechnology • Healthcare • Miami, FL, United States • LGVN (NCM)

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

844 470 2550 Life Science & Technology Park, Miami, FL 33136, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

MACD Signal: How LGVN stock reacts to inflationary pressures - Day Trade & Reliable Price Breakout Alerts - moha.gov.vn
moha.gov.vn • Dec 27
Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2025 Result - Yahoo Finance
Yahoo Finance • Nov 3
Longeveron Faces Nasdaq Delisting Notice for Stock Price - TipRanks
TipRanks • Sep 26
Longeveron stock soars after FDA approves IND for heart failure treatment - Investing.com
Investing.com • Jul 8
Longeveron (NASDAQ: LGVN) gets Canada patent on LOMECEL-B for frailty and NIDCM - Stock Titan
Stock Titan • Dec 2

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Longeveron Inc. had layoffs?
No layoff events have been recorded for Longeveron Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Longeveron Inc. have?
Longeveron Inc. has approximately 25 employees.
What industry is Longeveron Inc. in?
Longeveron Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Longeveron Inc. a publicly traded company?
Yes, Longeveron Inc. is publicly traded under the ticker symbol LGVN on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is Longeveron Inc. headquartered?
Longeveron Inc. is headquartered in Miami, FL, United States at Life Science & Technology Park, Miami, FL 33136, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.